{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:53:11Z","timestamp":1762001591890},"reference-count":33,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2002,7,1]]},"abstract":"<jats:p> PURPOSE: Little is known about the long-term efficacy or adverse effects of growth hormone (GH) replacement therapy in survivors of childhood acute lymphoblastic leukemia (ALL) who have GH deficiency. We investigated the adult height of patients who had received GH and estimated their risk of leukemia relapse or development of a second malignancy. <\/jats:p><jats:p> PATIENTS AND METHODS: Of 910 patients treated for ALL at a single institution, 47 had received GH replacement therapy. The linear growth of these 47 patients was retrospectively evaluated. Their risk of leukemia relapse or second malignancy was compared with that of survivors who did not undergo GH therapy. <\/jats:p><jats:p> RESULTS: The median height SD score at the start of GH therapy had decreased by 1.0 since the time of diagnosis of ALL. After a median duration of 4.5 years of GH therapy, adult height SD scores improved and approached height SD scores at the time of diagnosis of ALL. The median adult height for male patients was 173.2 cm (range, 157 to 191.9 cm), and for female patients, it was 158.1 cm (range, 141 to 168 cm). None of the patients developed adverse effects requiring discontinuation of GH treatment. At the 7-year and 11-year landmarks in continuous hematologic remission, there was no statistical evidence that GH therapy was associated with leukemia relapse or development of a second malignancy. <\/jats:p><jats:p> CONCLUSION: This study suggests that GH replacement therapy is safe and efficacious for the correction of GH deficiency in survivors of childhood ALL. <\/jats:p>","DOI":"10.1200\/jco.2002.09.142","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T20:11:44Z","timestamp":1034367104000},"page":"2959-2964","source":"Crossref","is-referenced-by-count":77,"title":["Outcomes of Growth Hormone Replacement Therapy in Survivors of Childhood Acute Lymphoblastic Leukemia"],"prefix":"10.1200","volume":"20","author":[{"given":"Wing","family":"Leung","sequence":"first","affiliation":[{"name":"From the After Completion of Therapy Program and the Departments of Hematology-Oncology, Biostatistics, and Pharmaceutical Sciences, St Jude Children\u2019s Research Hospital; and the Division of Endocrinology, Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan R.","family":"Rose","sequence":"additional","affiliation":[{"name":"From the After Completion of Therapy Program and the Departments of Hematology-Oncology, Biostatistics, and Pharmaceutical Sciences, St Jude Children\u2019s Research Hospital; and the Division of Endocrinology, Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinmei","family":"Zhou","sequence":"additional","affiliation":[{"name":"From the After Completion of Therapy Program and the Departments of Hematology-Oncology, Biostatistics, and Pharmaceutical Sciences, St Jude Children\u2019s Research Hospital; and the Division of Endocrinology, Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael L.","family":"Hancock","sequence":"additional","affiliation":[{"name":"From the After Completion of Therapy Program and the Departments of Hematology-Oncology, Biostatistics, and Pharmaceutical Sciences, St Jude Children\u2019s Research Hospital; and the Division of Endocrinology, Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Burstein","sequence":"additional","affiliation":[{"name":"From the After Completion of Therapy Program and the Departments of Hematology-Oncology, Biostatistics, and Pharmaceutical Sciences, St Jude Children\u2019s Research Hospital; and the Division of Endocrinology, Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Schriock","sequence":"additional","affiliation":[{"name":"From the After Completion of Therapy Program and the Departments of Hematology-Oncology, Biostatistics, and Pharmaceutical Sciences, St Jude Children\u2019s Research Hospital; and the Division of Endocrinology, Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Lustig","sequence":"additional","affiliation":[{"name":"From the After Completion of Therapy Program and the Departments of Hematology-Oncology, Biostatistics, and Pharmaceutical Sciences, St Jude Children\u2019s Research Hospital; and the Division of Endocrinology, Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert K.","family":"Danish","sequence":"additional","affiliation":[{"name":"From the After Completion of Therapy Program and the Departments of Hematology-Oncology, Biostatistics, and Pharmaceutical Sciences, St Jude Children\u2019s Research Hospital; and the Division of Endocrinology, Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William E.","family":"Evans","sequence":"additional","affiliation":[{"name":"From the After Completion of Therapy Program and the Departments of Hematology-Oncology, Biostatistics, and Pharmaceutical Sciences, St Jude Children\u2019s Research Hospital; and the Division of Endocrinology, Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa M.","family":"Hudson","sequence":"additional","affiliation":[{"name":"From the After Completion of Therapy Program and the Departments of Hematology-Oncology, Biostatistics, and Pharmaceutical Sciences, St Jude Children\u2019s Research Hospital; and the Division of Endocrinology, Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Hon","family":"Pui","sequence":"additional","affiliation":[{"name":"From the After Completion of Therapy Program and the Departments of Hematology-Oncology, Biostatistics, and Pharmaceutical Sciences, St Jude Children\u2019s Research Hospital; and the Division of Endocrinology, Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"R1-110616","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199808273390907"},{"key":"R2-110616","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950130105"},{"key":"R3-110616","doi-asserted-by":"crossref","unstructured":"Kirk  JA,   Raghupathy  P,   Stevens  MM,  et al:   Growth failure and growth-hormone deficiency after treatment for acute lymphoblastic leukaemia.  Lancet 1:  190,1987-193,","DOI":"10.1016\/S0140-6736(87)90004-3"},{"key":"R4-110616","doi-asserted-by":"crossref","unstructured":"Clayton  PE,   Shalet  SM,   Morris-Jones  PH,  et al:   Growth in children treated for acute lymphoblastic leukaemia.  Lancet 2:  164,1988","DOI":"10.1016\/S0140-6736(88)90715-5"},{"key":"R5-110616","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.3.400"},{"key":"R6-110616","doi-asserted-by":"publisher","DOI":"10.1159\/000181030"},{"key":"R7-110616","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)81537-9"},{"key":"R8-110616","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)80948-5"},{"key":"R9-110616","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(84)80989-0"},{"key":"R10-110616","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-911X(200001)34:1<14::AID-MPO3>3.0.CO;2-W"},{"key":"R11-110616","unstructured":"Pui  CH,   Aur  RJ,   Bowman  WP,  et al:   Failure of late intensification therapy to improve a poor result in childhood lymphoblastic leukemia.  Cancer Res 44:  3593,1984-3598,"},{"key":"R12-110616","unstructured":"Pui  CH,   Simone  JV,   Hancock  ML,  et al:   Impact of three methods of treatment intensification on acute lymphoblastic leukemia in children:  Long-term results of St Jude total therapy study X.   Leukemia 6:  150,1992-157,"},{"key":"R13-110616","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)90733-6"},{"key":"R14-110616","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199802193380803"},{"key":"R15-110616","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198807283190403"},{"key":"R16-110616","doi-asserted-by":"publisher","DOI":"10.1136\/adc.58.10.767"},{"key":"R17-110616","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.18.3273"},{"key":"R18-110616","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20011001)92:7<1959::AID-CNCR1715>3.0.CO;2-Y"},{"key":"R20-110616","doi-asserted-by":"publisher","DOI":"10.1214\/aos\/1176350951"},{"key":"R21-110616","doi-asserted-by":"publisher","DOI":"10.2307\/2533069"},{"key":"R22-110616","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.82.2.3734"},{"key":"R23-110616","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)01038-0"},{"key":"R24-110616","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200009283431304"},{"key":"R25-110616","doi-asserted-by":"crossref","unstructured":"Rogers  PC,   Komp  D,   Rogol  A,  et al:   Possible effects of growth hormone on development of acute lymphoblastic leukemia.  Lancet 2:  434,1977-435,","DOI":"10.1016\/S0140-6736(77)90613-4"},{"key":"R26-110616","doi-asserted-by":"crossref","unstructured":"Watanabe  S,   Tsunematsu  Y,   Fujimoto  J,  et al:   Leukemia in patients treated with growth hormone.  Lancet 1:  1159,1988-1160,    (letter)","DOI":"10.1016\/S0140-6736(88)91968-X"},{"key":"R27-110616","doi-asserted-by":"crossref","unstructured":"Delemarre-Van de Waal  HA,   Odink  RJH,   De Grauw  TJ,  et al:   Leukemia in patients treated with growth hormone.  Lancet 1:  1159,1988-1160,    (letter)","DOI":"10.1016\/S0140-6736(88)91968-X"},{"key":"R28-110616","doi-asserted-by":"crossref","unstructured":"Fisher  DA,   Job  JC,   Preece  M,  et al:   Leukemia in patients treated with growth hormone.  Lancet 1:  1159,1988-1160,    (letter)","DOI":"10.1016\/S0140-6736(88)91968-X"},{"key":"R29-110616","doi-asserted-by":"crossref","unstructured":"Frisch  H,   Thun-Hohenstein  L,   Balzar  E:   Leukemia and growth hormone.  Lancet 1:  1335,1988  (letter)","DOI":"10.1016\/S0140-6736(88)92147-2"},{"key":"R30-110616","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1993.03510230067037"},{"key":"R31-110616","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(97)70008-8"},{"key":"R32-110616","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.6.5716"},{"key":"R33-110616","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199111073251902"},{"key":"R34-110616","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199910143411607"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2002.09.142","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T21:51:01Z","timestamp":1653515461000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2002.09.142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7,1]]},"references-count":33,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2002,7,1]]}},"alternative-id":["10.1200\/JCO.2002.09.142"],"URL":"https:\/\/doi.org\/10.1200\/jco.2002.09.142","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,7,1]]}}}